BE2014C063I2 - - Google Patents

Download PDF

Info

Publication number: BE2014C063I2
Authority: BE; Belgium

Application number

BE2014C063C

Other languages

French (fr)

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-27

Filing date

2014-10-02

Publication date

2024-08-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35242158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2014C063(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-10-02 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2024-08-08 Publication of BE2014C063I2 publication Critical patent/BE2014C063I2/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)

BE2014C063C 2004-04-27 2014-10-02 BE2014C063I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US56562304P	2004-04-27	2004-04-27

Publications (1)

Publication Number	Publication Date
BE2014C063I2 true BE2014C063I2 (en)	2024-08-08

Family

ID=35242158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2014C063C BE2014C063I2 (en)	2004-04-27	2014-10-02

Country Status (38)

Country	Link
US (9)	US7498440B2 (en)
EP (3)	EP3111936A1 (en)
JP (2)	JP5014121B2 (en)
KR (2)	KR101037026B1 (en)
CN (2)	CN102040602A (en)
AP (1)	AP2213A (en)
AR (1)	AR050902A1 (en)
AU (1)	AU2005237576B2 (en)
BE (1)	BE2014C063I2 (en)
BR (1)	BRPI0510170B8 (en)
CA (2)	CA2755954C (en)
CY (3)	CY1113196T1 (en)
DK (2)	DK1740177T3 (en)
EA (2)	EA021994B1 (en)
EC (1)	ECSP066940A (en)
ES (2)	ES2392848T4 (en)
FR (1)	FR14C0075I2 (en)
HR (2)	HRP20120832T1 (en)
HU (2)	HUE031304T2 (en)
IL (1)	IL178152A (en)
LT (1)	LT2570128T (en)
LU (1)	LU92565I2 (en)
MA (1)	MA28631B1 (en)
MX (1)	MXPA06012405A (en)
MY (1)	MY144753A (en)
NL (1)	NL300694I1 (en)
NO (3)	NO338959B1 (en)
NZ (1)	NZ549997A (en)
PE (1)	PE20060259A1 (en)
PL (2)	PL2570128T3 (en)
PT (2)	PT1740177E (en)
SG (1)	SG186597A1 (en)
SI (2)	SI1740177T1 (en)
TW (1)	TWI363759B (en)
UA (1)	UA95768C2 (en)
UY (1)	UY28871A1 (en)
WO (1)	WO2005104745A2 (en)
ZA (1)	ZA200608565B (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR045914A1 (en) *	2003-07-17	2005-11-16	Glaxo Group Ltd	TERTIARY ALCOHOLIC COMPOUND OF 8-AZONIABICICLO [3.2.1] OCTOBER, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE THIS LAST
EP1677796A4 (en) *	2003-10-17	2006-12-27	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention
PE20050489A1 (en) *	2003-11-04	2005-09-02	Glaxo Group Ltd	ANTAGONISTS OF MUSCARINE ACETYLCHOLINE RECEPTORS
WO2005087236A1 (en) *	2004-03-11	2005-09-22	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
US7384946B2 (en) *	2004-03-17	2008-06-10	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
EP1725238A4 (en) *	2004-03-17	2009-04-01	Glaxo Group Ltd	ACETYLCHOLINE M 3 MUSCARINIC RECEPTOR ANTAGONISTS
JP2007531792A (en) *	2004-04-05	2007-11-08	サマリタン，ファーマスーティカルス，インク．	Anti-HIV quinuclidine compounds
UY28871A1 (en)	2004-04-27	2005-11-30	Glaxo Group Ltd	ANTAGONISTS OF THE MUSCARINIC ACETILCOLINE RECEIVER
EP1747219A4 (en) *	2004-05-13	2010-05-26	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
JP2008520579A (en) *	2004-11-15	2008-06-19	グラクソグループリミテッド	Novel M3 muscarinic acetylcholine receptor antagonist
US20080275079A1 (en) *	2005-08-02	2008-11-06	Glaxo Group Limited	M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007022351A2 (en) *	2005-08-18	2007-02-22	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
KR20090003349A (en)	2006-04-20	2009-01-09	글락소 그룹 리미티드	compound
GB0611587D0 (en)	2006-06-12	2006-07-19	Glaxo Group Ltd	Novel compounds
PT2046787E (en)	2006-08-01	2011-06-15	Glaxo Group Ltd	Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
PE20081889A1 (en)	2007-03-23	2009-03-05	Smithkline Beecham Corp	INDOL CARBOXAMIDES AS INHIBITORS OF IKK2
AR070563A1 (en)	2008-02-06	2010-04-21	Glaxo Group Ltd	COMPOSITE OF A CONDENSED BICYCLE PIRAZOL-PIRIDIN-AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICATION FOR THE TREATMENT OF RESPIRATORY DISEASES.
PE20091552A1 (en)	2008-02-06	2009-10-25	Glaxo Group Ltd	DUAL PHARMACOFOROS - PDE4 MUSCARINIC ANTAGONISTS
PE20091553A1 (en)	2008-02-06	2009-10-30	Glaxo Group Ltd	DUAL PHARMACOFOROS - PDE4 MUSCARINIC ANTAGONISTS
JP5502858B2 (en)	2008-06-05	2014-05-28	グラクソグループリミテッド	4-Carboxamide indazole derivatives useful as inhibitors of PI3 kinase
JP5502077B2 (en)	2008-06-05	2014-05-28	グラクソグループリミテッド	New compounds
WO2010094643A1 (en)	2009-02-17	2010-08-26	Glaxo Group Limited	Quinoline derivatives and their uses for rhinitis and urticaria
JP5809985B2 (en)	2009-02-26	2015-11-11	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	A medicament comprising 4-{(1R) -2-[(6- {2-[(2,6-dichlorobenzyl) oxy] ethoxy} hexyl) amino] -1-hydroxyethyl} -2- (hydroxymethyl) phenol Formulation
EP2406255B1 (en)	2009-03-09	2015-04-29	Glaxo Group Limited	4-oxadiazol-2-yl-indazoles as inhibitors of pi3 kinases
WO2010102968A1 (en)	2009-03-10	2010-09-16	Glaxo Group Limited	Indole derivatives as ikk2 inhibitors
WO2010106016A1 (en)	2009-03-17	2010-09-23	Glaxo Group Limited	Pyrimidine derivatives used as itk inhibitors
AR076435A1 (en)	2009-04-30	2011-06-08	Glaxo Group Ltd	COMPOUNDS OF REPLACED INDAZOLS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCESSES TO OBTAIN THEMSELVES
WO2011029896A1 (en)	2009-09-11	2011-03-17	Glaxo Group Limited	Methods of preparation of muscarinic acetylcholine receptor antagonists
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
JP2013512880A (en)	2009-12-03	2013-04-18	グラクソグループリミテッド	Indazole derivatives as PI3-kinase inhibitors
JP2013512878A (en)	2009-12-03	2013-04-18	グラクソグループリミテッド	New compounds
WO2011067365A1 (en)	2009-12-03	2011-06-09	Glaxo Group Limited	Benzpyrazole derivatives as inhibitors of p13 kinases
KR101781237B1 (en) *	2010-01-28	2017-09-22	테론 파마슈티칼즈, 인크.	7-azoniabicyclo〔2.2.1〕heptane derivatives, methods of production, and pharmaceutical uses thereof
WO2011110575A1 (en)	2010-03-11	2011-09-15	Glaxo Group Limited	Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
UA107499C2 (en) *	2010-06-22	2015-01-12	Chiesi Farm Spa	DRY POWDER COMPOSITION CONTAINING ANTIMUSCARIN
RS54286B1 (en)	2010-09-08	2016-02-29	Glaxosmithkline Intellectual Property Development Limited	POLYMORPHS AND SALTS N- [5- [4- (5 - {[(2R, 6S) -2,6-DIMETHYL-4-MORPHOLINYL] METHYL} -1,3-OXAZOL-2-yl) -1H-INDAZZOL- 6-IL] -2 (methyloxy) -3-pyridinyl] -methanesulfonamide
WO2012035055A1 (en)	2010-09-17	2012-03-22	Glaxo Group Limited	Novel compounds
GB201018124D0 (en)	2010-10-27	2010-12-08	Glaxo Group Ltd	Polymorphs and salts
KR20140041700A (en)	2011-06-08	2014-04-04	글락소 그룹 리미티드	Dry powder inhaler compositions comprising umeclidinium
US20140113888A1 (en)	2011-06-08	2014-04-24	Glaxo Group Limited	Novel Combination of Therapeutic Agents
US9763965B2 (en)	2012-04-13	2017-09-19	Glaxosmithkline Intellectual Property Development Limited	Aggregate particles
RU2502743C1 (en) *	2012-08-03	2013-12-27	Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения и социального развития РФ (ФГБУ "РКНПК" Минздравсоцразвития России)	Synthetic antigen having ability to fix autoantibodies to muscarine m2-receptor
WO2014027045A1 (en)	2012-08-15	2014-02-20	Glaxo Group Limited	Chemical process
GB201222679D0 (en)	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
CN105431432B (en) *	2013-07-13	2018-01-09	北京硕佰医药科技有限责任公司	Quinine class compound, its optical isomer and preparation method thereof and medical usage
EA201690302A1 (en) *	2013-07-30	2016-06-30	Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед	COMPOSITIONS FOR LOCAL APPLICATION FOR THE TREATMENT OF EXCESS MEANS AND METHODS OF THEIR APPLICATION
JP2016537327A (en)	2013-10-17	2016-12-01	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	PI3K inhibitors for the treatment of respiratory diseases
RU2016112266A (en)	2013-10-17	2017-11-20	Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед	PI3K inhibitor for the treatment of respiratory disease
WO2015173701A2 (en)	2014-05-12	2015-11-19	Glaxosmithkline Intellectual Property (No. 2) Limited	Pharmaceutical compositions for treating infectious diseases
EP3650019B8 (en)	2014-05-28	2023-10-11	GlaxoSmithKline Intellectual Property Development Limited	Fluticasone furoate in the treatment of copd
JP6615212B2 (en) *	2014-11-03	2019-12-04	オロンソシエタペルアチオニ	Preparation of 1- (2-halogen-ethyl) -4-piperidinecarboxylic acid ethyl ester
KR101613245B1 (en)	2015-04-27	2016-04-18	주식회사 대웅제약	Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
CN105461710A (en) *	2015-10-23	2016-04-06	安徽德信佳生物医药有限公司	Preparation method of umeclidinium bromide
KR102794286B1 (en) *	2016-01-08	2025-04-09	테론 파마슈티칼즈, 인크.	Dry powder inhaler composition of 7-azoniabicyclo[2.2.1]heptane derivative
GB201602527D0 (en)	2016-02-12	2016-03-30	Glaxosmithkline Ip Dev Ltd	Chemical compounds
CN107200734B (en) *	2016-03-18	2019-12-24	益方生物科技（上海）有限公司	Quinuclidine derivative and preparation method and application thereof
EP3248970A1 (en)	2016-05-27	2017-11-29	Zentiva K.S.	Forms of umeclidinium bromide
JP2019524792A (en)	2016-08-08	2019-09-05	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	Compound
PT109740B (en)	2016-11-14	2020-07-30	Hovione Farmaciencia Sa	PROCESS FOR THE PREPARATION OF UMECLIDINUM BROMIDE
WO2018163212A1 (en) *	2017-03-08	2018-09-13	Gbr Laboratories Pvt. Ltd	A process for the preparation of umeclidinium bromide and intermediates thereof
GB201706102D0 (en)	2017-04-18	2017-05-31	Glaxosmithkline Ip Dev Ltd	Chemical compounds
IT201700058796A1 (en)	2017-05-30	2018-11-30	Olon Spa	Procedure for the preparation of a new intermediate of synthesis of umeclidinium.
GB201712081D0 (en)	2017-07-27	2017-09-13	Glaxosmithkline Ip Dev Ltd	Chemical compounds
JP7432506B2 (en)	2017-10-30	2024-02-16	武田薬品工業株式会社	Environmentally compatible surfactants for inactivating lipid enveloped viruses
CN108558860B (en) *	2018-06-04	2020-12-25	成都伊诺达博医药科技有限公司	Method for synthesizing umeclidinium bromide
WO2020047225A1 (en)	2018-08-30	2020-03-05	Theravance Biopharma R&D Ip, Llc	Methods for treating chronic obstructive pulmonary disease
PT115583B (en)	2019-06-17	2022-05-02	Hovione Farm S A	CONTINUOUS PROCESS FOR THE PREPARATION OF ANTICHOLINERGIC DRUGS
CN113387923A (en) *	2020-03-13	2021-09-14	诺华股份有限公司	Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using the same
BR112022019245A2 (en)	2020-03-26	2022-11-16	Glaxosmithkline Ip Dev Ltd	CATHEPSIN INHIBITORS TO PREVENT OR TREAT VIRAL INFECTIONS
CN111484445B (en) *	2020-04-21	2021-05-18	广东莱佛士制药技术有限公司	Method for separating and purifying the intermediate of high-purity umeclidinium bromide
CN115397823B (en) *	2020-04-26	2025-11-11	北京硕佰医药科技有限责任公司	Crystal of M receptor antagonist, preparation method and application thereof
CA3192236A1 (en)	2020-09-10	2022-03-17	Tony Lahoutte	Antibody fragment against fap
CN112479983B (en) *	2020-11-25	2022-07-12	江苏豪森药业集团有限公司	Wumei ammonium bromide intermediate and preparation method thereof
PT117440B (en)	2021-09-03	2024-04-26	Hovione Farm S A	PROCESS FOR THE PREPARATION OF CHLOROAQUIL SUBSTITUTED CYCLIC AMINES
WO2023203135A1 (en)	2022-04-22	2023-10-26	Precirix N.V.	Improved radiolabelled antibody
AU2023264245A1 (en)	2022-05-02	2024-12-19	Precirix N.V.	Pre-targeting
WO2024251812A1 (en)	2023-06-07	2024-12-12	Pharmazell Gmbh	A process for the preparation of umeclidinium bromide intermediate

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2800478A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800481A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (en)	1967-06-08	1972-04-25	Siemens Ag	Method for converting voltages into digital values and device for carrying out the method
GB1242211A (en)	1967-08-08	1971-08-11	Fisons Pharmaceuticals Ltd	Pharmaceutical composition
GB1230087A (en)	1967-08-17	1971-04-28
GB1381872A (en)	1971-06-22	1975-01-29	Fisons Ltd	Pharmaceutical compositions for inhalation
CY1308A (en)	1979-12-06	1985-12-06	Glaxo Group Ltd	Device for dispensing medicaments
ATE23272T1 (en)	1981-07-08	1986-11-15	Draco Ab	POWDER INHALER.
GB2169265B (en)	1982-10-08	1987-08-12	Glaxo Group Ltd	Pack for medicament
NL192564C (en)	1982-10-08	1997-10-03	Glaxo Group Ltd	Device for administering medicaments to patients.
EP0211595B1 (en)	1985-07-30	1991-11-13	Glaxo Group Limited	Devices for administering medicaments to patients
IT1204826B (en)	1986-03-04	1989-03-10	Chiesi Farma Spa	INHALATION PHARMACEUTICAL COMPOSITIONS
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
US5780466A (en)	1995-01-30	1998-07-14	Sanofi	Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
AU5790598A (en)	1996-12-02	1998-06-29	Georgetown University	Tropane derivatives and method for their synthesis
US6248752B1 (en)	1998-02-27	2001-06-19	Charles Duane Smith	Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en)	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
CN1250545C (en) *	2000-12-28	2006-04-12	阿尔米雷尔普罗迪斯制药有限公司	Novel quinucidine derivatives and pharmaceutical compositions containing such derivatives
RU2004110717A (en)	2001-10-17	2005-10-20	Юсиби, С.А. (Be)	Quinuclidine derivatives, methods for their preparation and their use as both M2- and / or M3-muscarinic receptors
US6951868B2 (en) *	2001-11-09	2005-10-04	Pfizer Inc.	Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
JP4505227B2 (en) *	2001-12-20	2010-07-21	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	1-Alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
US6696462B2 (en) *	2002-01-31	2004-02-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
ES2206021B1 (en)	2002-04-16	2005-08-01	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF PIRROLIDINIO.
ES2204295B1 (en) *	2002-07-02	2005-08-01	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF QUINUCLIDINE-AMIDE.
AR040779A1 (en)	2002-08-06	2005-04-20	Glaxo Group Ltd	TIAZOL COMPOUND ANILINATES ITS USE TO PREPARE A PHARMACEUTICAL FORMULATION SUCH RECENT FORMULATION CONTAINING IT AND DEVICE ADAPTED FOR THE INTRANASAL ADMINISTRATION OF THE FORMULATION
EP1613307A4 (en)	2003-04-07	2008-03-12	Glaxo Group Ltd	M sb 3 /sb muscarinic acetylcholine receptor antagonists
UY28417A1 (en)	2003-07-17	2005-02-28	Glaxo Group Ltd	ANTAGONISTS OF ACETILCOLINE MUSCARINIC RECEPTORS
AR048573A1 (en)	2003-07-17	2006-05-10	Glaxo Group Ltd	COMPOSITE OF 8-AZONIABICICLO [3.2.1] OCTANO REPLACED IN POSITION 3, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE THIS LAST
AR045914A1 (en) *	2003-07-17	2005-11-16	Glaxo Group Ltd	TERTIARY ALCOHOLIC COMPOUND OF 8-AZONIABICICLO [3.2.1] OCTOBER, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE THIS LAST
SI1677795T1 (en)	2003-10-14	2011-04-29	Glaxo Group Ltd	Muscarinic acetycholine receptor antagonists
EP1677796A4 (en)	2003-10-17	2006-12-27	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention
PE20050489A1 (en)	2003-11-04	2005-09-02	Glaxo Group Ltd	ANTAGONISTS OF MUSCARINE ACETYLCHOLINE RECEPTORS
ES2329586T3 (en)	2003-11-21	2009-11-27	Theravance, Inc.	COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE BETA2 ADRENERGIC RECEIVER AND ANTAGONIST OF THE MUSCARINE RECEIVER.
PE20050897A1 (en)	2003-12-03	2005-11-06	Glaxo Group Ltd	NEW ANTAGONISTS OF ACETYLCHOLIN MUSCARINE M3 RECEPTOR
TW200530226A (en)	2003-12-03	2005-09-16	Glaxo Group Ltd	Novel M3 muscarinic acetylcholine receptor antagonists
TW200534855A (en)	2004-01-13	2005-11-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
WO2005087236A1 (en)	2004-03-11	2005-09-22	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
US20070179131A1 (en)	2004-03-11	2007-08-02	Jian Jin	Novel M3 Muscarinic Acetylcholine Receptor Antagonists
JP2007529512A (en)	2004-03-17	2007-10-25	グラクソ　グループ　リミテッド	Muscarinic acetylcholine receptor antagonist
EP1725238A4 (en)	2004-03-17	2009-04-01	Glaxo Group Ltd	ACETYLCHOLINE M 3 MUSCARINIC RECEPTOR ANTAGONISTS
WO2005094835A1 (en)	2004-03-17	2005-10-13	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US7384946B2 (en)	2004-03-17	2008-06-10	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US20070238751A1 (en)	2004-04-07	2007-10-11	Laine Dramane I	Muscarinic Acetylcholine Receptor Antagonists
UY28871A1 (en)	2004-04-27	2005-11-30	Glaxo Group Ltd	ANTAGONISTS OF THE MUSCARINIC ACETILCOLINE RECEIVER
EP1747219A4 (en)	2004-05-13	2010-05-26	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention
WO2005118594A1 (en)	2004-05-28	2005-12-15	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
JP2008505118A (en)	2004-06-30	2008-02-21	グラクソ　グループ　リミテッド	Muscarinic acetylcholine receptor antagonist
EP1781104A4 (en)	2004-08-05	2008-05-21	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
WO2006017767A2 (en)	2004-08-06	2006-02-16	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
WO2006050239A2 (en)	2004-10-29	2006-05-11	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
EP1827439A4 (en)	2004-11-15	2009-11-18	Glaxo Group Ltd	Novel m3 muscarinic acetylcholine receptor antagonists
JP2008520579A (en)	2004-11-15	2008-06-19	グラクソグループリミテッド	Novel M3 muscarinic acetylcholine receptor antagonist
PE20061162A1 (en)	2004-12-06	2006-10-14	Smithkline Beecham Corp	COMPOUNDS OLEFINIC DERIVATIVES OF 8-AZONIABICICLO [3.2.1] OCTANES
PE20060826A1 (en)	2004-12-06	2006-10-08	Smithkline Beecham Corp	OLEOPHINIC DERIVATIVE OF 8-AZONIABICICLO [3.2.1] OCTANE AND THE PHARMACEUTICAL COMBINATION THAT INCLUDES IT
WO2006065755A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists
WO2006065788A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Novel muscarinic acetylcholine receptor antagonists
WO2007018514A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetycholine receptor antagonists
US20080275079A1 (en)	2005-08-02	2008-11-06	Glaxo Group Limited	M3 Muscarinic Acetylcholine Receptor Antagonists
US20080234315A1 (en)	2005-08-02	2008-09-25	Jakob Busch-Petersen	M3 Muscarinic Acetylcholine Receptor Antagonists
WO2007022351A2 (en)	2005-08-18	2007-02-22	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents

2005
- 2005-04-25 UY UY28871A patent/UY28871A1/en not_active Application Discontinuation
- 2005-04-25 TW TW094113034A patent/TWI363759B/en active
- 2005-04-25 PE PE2005000457A patent/PE20060259A1/en active IP Right Grant
- 2005-04-25 MY MYPI20051806A patent/MY144753A/en unknown
- 2005-04-25 AR ARP050101627A patent/AR050902A1/en active IP Right Grant
- 2005-04-27 PL PL12170402T patent/PL2570128T3/en unknown
- 2005-04-27 NZ NZ549997A patent/NZ549997A/en not_active IP Right Cessation
- 2005-04-27 CN CN2010105580787A patent/CN102040602A/en active Pending
- 2005-04-27 DK DK05746609.6T patent/DK1740177T3/en active
- 2005-04-27 EP EP16177012.8A patent/EP3111936A1/en not_active Withdrawn
- 2005-04-27 ES ES05746609.6T patent/ES2392848T4/en not_active Expired - Lifetime
- 2005-04-27 BR BRPI0510170A patent/BRPI0510170B8/en not_active IP Right Cessation
- 2005-04-27 PT PT05746609T patent/PT1740177E/en unknown
- 2005-04-27 SI SI200531605T patent/SI1740177T1/en unknown
- 2005-04-27 CA CA2755954A patent/CA2755954C/en not_active Expired - Lifetime
- 2005-04-27 MX MXPA06012405A patent/MXPA06012405A/en active IP Right Grant
- 2005-04-27 EP EP05746609A patent/EP1740177B1/en not_active Expired - Lifetime
- 2005-04-27 PT PT121704027T patent/PT2570128T/en unknown
- 2005-04-27 EA EA201100019A patent/EA021994B1/en not_active IP Right Cessation
- 2005-04-27 JP JP2007510915A patent/JP5014121B2/en not_active Expired - Lifetime
- 2005-04-27 CN CNA2005800215360A patent/CN1976701A/en active Pending
- 2005-04-27 LT LTEP12170402.7T patent/LT2570128T/en unknown
- 2005-04-27 US US11/568,330 patent/US7498440B2/en not_active Expired - Lifetime
- 2005-04-27 WO PCT/US2005/014386 patent/WO2005104745A2/en not_active Ceased
- 2005-04-27 SG SG2012087052A patent/SG186597A1/en unknown
- 2005-04-27 HU HUE12170402A patent/HUE031304T2/en unknown
- 2005-04-27 EA EA200601991A patent/EA015033B1/en not_active IP Right Cessation
- 2005-04-27 HR HRP20120832TT patent/HRP20120832T1/en unknown
- 2005-04-27 ES ES12170402.7T patent/ES2600405T3/en not_active Expired - Lifetime
- 2005-04-27 UA UAA200611253A patent/UA95768C2/en unknown
- 2005-04-27 KR KR1020067022276A patent/KR101037026B1/en not_active Expired - Lifetime
- 2005-04-27 PL PL05746609T patent/PL1740177T3/en unknown
- 2005-04-27 KR KR1020117001909A patent/KR101152032B1/en not_active Expired - Lifetime
- 2005-04-27 AU AU2005237576A patent/AU2005237576B2/en active Active
- 2005-04-27 DK DK12170402.7T patent/DK2570128T3/en active
- 2005-04-27 SI SI200532099A patent/SI2570128T1/en unknown
- 2005-04-27 EP EP12170402.7A patent/EP2570128B1/en not_active Expired - Lifetime
- 2005-04-27 CA CA2564742A patent/CA2564742C/en not_active Expired - Lifetime
- 2005-04-27 AP AP2006003746A patent/AP2213A/en active
2006
- 2006-09-18 IL IL178152A patent/IL178152A/en active Protection Beyond IP Right Term
- 2006-10-13 ZA ZA2006/08565A patent/ZA200608565B/en unknown
- 2006-10-20 EC EC2006006940A patent/ECSP066940A/en unknown
- 2006-10-31 MA MA29426A patent/MA28631B1/en unknown
- 2006-11-24 NO NO20065417A patent/NO338959B1/en active Protection Beyond IP Right Term
2007
- 2007-07-09 US US11/774,867 patent/US7488827B2/en active Active
2009
- 2009-01-14 US US12/353,436 patent/US8183257B2/en not_active Expired - Lifetime
2012
- 2012-02-22 US US13/401,890 patent/US8309572B2/en not_active Expired - Lifetime
- 2012-04-13 JP JP2012092339A patent/JP5398871B2/en not_active Expired - Lifetime
- 2012-09-26 US US13/627,007 patent/US8575347B2/en not_active Expired - Fee Related
- 2012-10-17 CY CY20121100965T patent/CY1113196T1/en unknown
2013
- 2013-10-14 US US14/052,816 patent/US8853404B2/en not_active Expired - Lifetime
2014
- 2014-09-04 US US14/476,940 patent/US9045469B2/en not_active Expired - Lifetime
- 2014-09-26 HU HUS1400053C patent/HUS1400053I1/en unknown
- 2014-10-02 LU LU92565C patent/LU92565I2/en unknown
- 2014-10-02 BE BE2014C063C patent/BE2014C063I2/fr unknown
- 2014-10-02 NL NL300694C patent/NL300694I1/nl unknown
- 2014-10-02 FR FR14C0075C patent/FR14C0075I2/en active Active
- 2014-10-03 CY CY2014043C patent/CY2014043I2/en unknown
2015
- 2015-05-08 US US14/707,543 patent/US9144571B2/en not_active Expired - Lifetime
- 2015-09-10 US US14/849,775 patent/US20160002220A1/en not_active Abandoned
2016
- 2016-10-10 CY CY20161101008T patent/CY1118082T1/en unknown
- 2016-10-25 HR HRP20161385TT patent/HRP20161385T1/en unknown
2017
- 2017-05-04 NO NO2017017C patent/NO2017017I1/en unknown
- 2017-05-04 NO NO2017018C patent/NO2017018I2/en unknown

Also Published As

Publication number	Publication date
ES2392848T4 (en)	2014-10-01
EA021994B1 (en)	2015-10-30
TW200605887A (en)	2006-02-16
SI1740177T1 (en)	2012-12-31
JP2007534769A (en)	2007-11-29
NO2017018I1 (en)	2017-05-04
EP3111936A1 (en)	2017-01-04
AP2213A (en)	2011-03-01
US7488827B2 (en)	2009-02-10
CN102040602A (en)	2011-05-04
CY2014043I1 (en)	2015-12-09
HRP20120832T1 (en)	2012-11-30
DK2570128T3 (en)	2016-11-07
NL300694I2 (en)	2015-12-29
US8183257B2 (en)	2012-05-22
WO2005104745A2 (en)	2005-11-10
NO20065417L (en)	2006-12-29
NO338959B1 (en)	2016-11-07
LT2570128T (en)	2016-10-10
BRPI0510170B1 (en)	2018-12-18
PT2570128T (en)	2016-10-07
LU92565I9 (en)	2019-01-17
EA200601991A1 (en)	2007-02-27
NO2017017I1 (en)	2017-05-04
ECSP066940A (en)	2006-12-20
KR101152032B1 (en)	2012-06-11
MA28631B1 (en)	2007-06-01
WO2005104745A3 (en)	2006-08-03
CY1118082T1 (en)	2017-06-28
NZ549997A (en)	2010-10-29
EA015033B1 (en)	2011-04-29
CA2564742C (en)	2012-01-10
MXPA06012405A (en)	2007-01-17
NL300694I1 (en)	2015-12-29
PE20060259A1 (en)	2006-03-25
US8575347B2 (en)	2013-11-05
JP5398871B2 (en)	2014-01-29
US20140371264A1 (en)	2014-12-18
JP5014121B2 (en)	2012-08-29
CA2564742A1 (en)	2005-11-10
FR14C0075I1 (en)	2014-11-21
JP2012162559A (en)	2012-08-30
ES2600405T3 (en)	2017-02-08
SI2570128T1 (en)	2016-11-30
AU2005237576B2 (en)	2012-01-12
US7498440B2 (en)	2009-03-03
US20090124653A1 (en)	2009-05-14
TWI363759B (en)	2012-05-11
NO2017018I2 (en)	2018-05-14
AU2005237576A1 (en)	2005-11-10
PT1740177E (en)	2012-11-02
LU92565I2 (en)	2014-12-02
UA95768C2 (en)	2011-09-12
UY28871A1 (en)	2005-11-30
US9144571B2 (en)	2015-09-29
MY144753A (en)	2011-10-31
ZA200608565B (en)	2019-12-18
US8309572B2 (en)	2012-11-13
CA2755954C (en)	2014-02-18
US20120157491A1 (en)	2012-06-21
EP1740177A4 (en)	2010-05-05
FR14C0075I2 (en)	2015-05-22
EP1740177B1 (en)	2012-08-08
KR101037026B1 (en)	2011-05-25
BRPI0510170A (en)	2007-10-02
US20130030015A1 (en)	2013-01-31
HK1102423A1 (en)	2007-11-23
CN1976701A (en)	2007-06-06
DK1740177T3 (en)	2012-10-29
EA201100019A1 (en)	2011-12-30
CA2755954A1 (en)	2005-11-10
PL1740177T3 (en)	2012-12-31
US9045469B2 (en)	2015-06-02
SG186597A1 (en)	2013-01-30
US8853404B2 (en)	2014-10-07
IL178152A (en)	2011-05-31
AR050902A1 (en)	2006-12-06
US20070185155A1 (en)	2007-08-09
HUS1400053I1 (en)	2017-07-28
IL178152A0 (en)	2006-12-31
EP1740177A2 (en)	2007-01-10
HUE031304T2 (en)	2017-07-28
HRP20161385T1 (en)	2016-12-02
ES2392848T3 (en)	2012-12-14
CY2014043I2 (en)	2015-12-09
KR20110010841A (en)	2011-02-07
PL2570128T3 (en)	2017-09-29
US20150238470A1 (en)	2015-08-27
EP2570128A1 (en)	2013-03-20
AP2006003746A0 (en)	2006-10-31
EP2570128B1 (en)	2016-08-10
KR20070015412A (en)	2007-02-02
CY1113196T1 (en)	2015-12-09
BRPI0510170B8 (en)	2021-05-25
US20160002220A1 (en)	2016-01-07
US20070249664A1 (en)	2007-10-25
US20140080863A1 (en)	2014-03-20

Publication	Publication Date	Title
BE2020C513I2 (en)	2024-08-08
NL300694I2 (en)	2015-12-29
JP2004332738A5 (en)	2007-06-21
BR122015024347A2 (en)	2006-12-26
BE2016C042I2 (en)	2024-08-08
BE2014C002I2 (en)	2024-08-08
JP2006166641A5 (en)	2008-01-31
JP2005134370A5 (en)	2007-09-13
JP2005231573A5 (en)	2005-12-08
TWI346455B (en)	2011-08-01
JP2005014207A5 (en)	2007-02-15
CN300894877S (zh)	2009-03-25	服装（南航空姐立领连衣裙）
CN301067823S (zh)	2009-11-25	促销用装置
CN300859090S (zh)	2008-12-10	促销用装置
CN300764069S (zh)	2008-04-09	便携式媒体播放机
CN300846738S (zh)	2008-11-05	水龙头
AU2004203751A1 (en)	2004-07-22
ECSDI045450S (en)	2005-08-11
CN3366156S (en)	2004-05-05
CN3363656S (en)	2004-04-21
CN3350325S (en)	2004-01-28
CN3368601S (en)	2004-05-19
CN3366641S (en)	2004-05-05
CN3377649S (en)	2004-07-07
CN3378803S (en)	2004-07-14